N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141127 |
| CAS No | NA |
| Mol.F. | C8H8ClN3O2 |
| Mol.Wt. | 213.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141128 |
| CAS No | NA |
| Mol.F. | C17H15BrFN5O2 |
| Mol.Wt. | 420.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141129 |
| CAS No | NA |
| Mol.F. | C14H21N3O |
| Mol.Wt. | 247.3 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141130 |
| CAS No | NA |
| Mol.F. | C16H21N7O2 |
| Mol.Wt. | 343.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141131 |
| CAS No | NA |
| Mol.F. | C10H16N4O2 |
| Mol.Wt. | 224.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141132 |
| CAS No | NA |
| Mol.F. | C7H15N3O |
| Mol.Wt. | 157.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141133 |
| CAS No | NA |
| Mol.F. | C7H15N3O |
| Mol.Wt. | 157.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141134 |
| CAS No | NA |
| Mol.F. | C7H14N4O2 |
| Mol.Wt. | 186.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141135 |
| CAS No | NA |
| Mol.F. | C13H18N6O |
| Mol.Wt. | 274.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141136 |
| CAS No | NA |
| Mol.F. | C20H24N6O |
| Mol.Wt. | 364.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141137 |
| CAS No | NA |
| Mol.F. | C16H22N6O2 |
| Mol.Wt. | 330.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141138 |
| CAS No | NA |
| Mol.F. | C15H17N7O2 |
| Mol.Wt. | 327.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141139 |
| CAS No | NA |
| Mol.F. | C16H19N7O2 |
| Mol.Wt. | 341.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141140 |
| CAS No | NA |
| Mol.F. | C17H20N6O2 |
| Mol.Wt. | 340.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141141 |
| CAS No | NA |
| Mol.F. | C6H7F3N6O3 |
| Mol.Wt. | 268.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141142 |
| CAS No | NA |
| Mol.F. | C39H44N8O6 |
| Mol.Wt. | 720.8 |
| INV STATUS | CUSTOM SYNTHESIS |